Diagnos Medical Systems (TSX: ADK.V) logo — Deep learning-powered technology capable of diagnosing a wid...

Diagnos Medical Systems (TSX: ADK.V)

Deep learning-powered technology capable of diagnosing a wide range of retinal conditions.

Founded 1998 Canada Brossard, Canada 28 employees Post-IPO Equity Total: $22.03M Data Analytics, Medical Devices

General Information

Company Name Diagnos Medical Systems (TSX: ADK.V)
Founded Year 1998
Location Canada Brossard, Canada
Employees 28
Industries Data Analytics, Medical Devices
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Diagnos Medical Systems (TSX: ADK.V). To contact Diagnos Medical Systems (TSX: ADK.V), visit diagnos.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Diagnos Medical Systems (TSX: ADK.V) compare?

A PDF of Diagnos Medical Systems (TSX: ADK.V) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Diagnos Medical Systems (TSX: ADK.V) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Diagnos Medical Systems (TSX: ADK.V)

Diagnos is a well-established company that was founded in 1998. The company operates in the healthcare industry but specific details regarding its headquarters or slogan are not available. Despite being founded in the late 90s, Diagnos managed to secure a significant $1.30M investment through Post-IPO Equity at 09 May 2024, showcasing the enduring investor confidence in the company's offerings. However, information about the specific investors involved in this last investment round is not disclosed. It is clear that Diagnos has garnered interest and support in the form of financial backing, and this latest investment could indicate a promising future for the company, particularly in the evolving healthcare and technology landscapes.

Funding Rounds & Investors (14)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $1.30M -
09 May 2024
Post IPO Equity $578.00K -
27 Feb 2024
Post IPO Equity $640.05K -
04 Dec 2023
Post IPO Debt $2.00M 1
Government Of Quebec
08 Sep 2020
Post IPO Equity $2.96M -
24 Feb 2020
Post IPO Equity $550.00K -
13 Sep 2019
Post IPO Equity $1.15M -
06 Nov 2018
Post IPO Equity $2.29M -
30 Jul 2015
Post IPO Equity $1.40M -
17 Jan 2013
Post IPO Equity $3.22M -
26 Apr 2011

View All 14 Funding Rounds

FAQ About Diagnos Medical Systems (TSX: ADK.V)

Deep learning-powered technology capable of diagnosing a wide range of retinal conditions.
Diagnos Medical Systems (TSX: ADK.V) was founded in 1998.
Diagnos Medical Systems (TSX: ADK.V) is headquartered in Brossard, Canada.
Diagnos Medical Systems (TSX: ADK.V) operates in Data Analytics and Medical Devices.
Diagnos Medical Systems (TSX: ADK.V) has approximately 28 employees.
Diagnos Medical Systems (TSX: ADK.V) has completed 14 funding rounds, raising a total of $22.03M. The latest funding stage is Post-IPO Equity.

We're actively collecting intelligence on Diagnos Medical Systems (TSX: ADK.V).

Source: BounceWatch company record for Diagnos Medical Systems (TSX: ADK.V), https://bouncewatch.com/company/diagnos, updated 30 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes